The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-N-(4-((3-Cyano-1-isobutyl-1H-indol-5-yl)methyl)phenyl)pyrrolidine-2-carboxamide ID: ALA3421736
PubChem CID: 118735145
Max Phase: Preclinical
Molecular Formula: C25H28N4O
Molecular Weight: 400.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)Cn1cc(C#N)c2cc(Cc3ccc(NC(=O)[C@@H]4CCCN4)cc3)ccc21
Standard InChI: InChI=1S/C25H28N4O/c1-17(2)15-29-16-20(14-26)22-13-19(7-10-24(22)29)12-18-5-8-21(9-6-18)28-25(30)23-4-3-11-27-23/h5-10,13,16-17,23,27H,3-4,11-12,15H2,1-2H3,(H,28,30)/t23-/m0/s1
Standard InChI Key: KFEALFUIWDTBKJ-QHCPKHFHSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
-3.6187 1.4919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6267 2.9927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9282 3.7385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9331 5.2385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6365 5.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3350 5.2470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3301 3.7470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6383 7.4936 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3399 8.2464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2998 7.6480 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3417 9.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1310 10.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5992 12.0361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0992 12.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5581 10.6031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1783 2.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5503 3.7690 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6552 -2.9294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0330 -4.0684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4530 -2.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
2 1 1 0
1 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
14 17 1 0
17 18 1 0
18 19 2 0
20 18 1 1
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 1 0
8 25 1 0
10 26 1 0
26 27 3 0
25 28 1 0
28 29 1 0
28 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 400.53Molecular Weight (Monoisotopic): 400.2263AlogP: 4.45#Rotatable Bonds: 6Polar Surface Area: 69.85Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.53CX Basic pKa: 9.48CX LogP: 4.85CX LogD: 2.79Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.64Np Likeness Score: -1.12
References 1. Boyd S, Brookfield JL, Critchlow SE, Cumming IA, Curtis NJ, Debreczeni J, Degorce SL, Donald C, Evans NJ, Groombridge S, Hopcroft P, Jones NP, Kettle JG, Lamont S, Lewis HJ, MacFaull P, McLoughlin SB, Rigoreau LJ, Smith JM, St-Gallay S, Stock JK, Turnbull AP, Wheatley ER, Winter J, Wingfield J.. (2015) Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3., 58 (8): [PMID:25849762 ] [10.1021/acs.jmedchem.5b00352 ]